Report: Tylenol Maker Privately Admitted Likely Autism Link
28th September 2025
Kenvue, the maker of Tylenol, in 2018 privately admitted the likelihood of an association between the drug in pregnancy and neurodevelopmental disorders, according to a report by the Daily Caller.
“The weight of the evidence is starting to feel heavy to me,” Rachel Weinstein, U.S. director of epidemiology for Janssen, the pharmaceutical arm of Johnson & Johnson, said in company documents obtained by the Daily Caller from the law firm Keller Postman LLC, which brought a class action lawsuit against Kenvue in the Federal District Court for the Southern District of New York.
“We are talking with Rachel Ochs-Ross, the neurologist in CNS [Central Nervous System] today. Originally it was to talk about biologic plausibility for benefiting acetaminophen, but now we’ve added the studies in prenatal exposure and neurodev outcome.”